Fox Rothschild's Mark Wagner on why the FDA counts 70 drugs in shortage while ASHP counts 188 — and what's driving the gap.
Marc Wagner
Advertisement
Marc Wagner is an FDA and life sciences attorney at Fox Rothchild.
Articles by Marc Wagner
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
The Manufacturing Issues That Continue to Contribute to Drug Shortages
2
Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing
3
FDA Approves Tecentriq for Stage III dMMR Colon Cancer
4
Viatris Acquires Pacira BioSciences for $1.65 Billion
5